Search - tctmd.com

Displaying 881 - 900 of 1185

Sort: Relevancy | Date

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

July 25, 2013

News Daily News

Duplication of Invasive Services Still Leaves Many Patients Without Timely Access

July 25, 2013

News Daily News

Declaración Pública de Rehospitalizaciones PCI aunque Algunos Cuestionan los Resultados

Caitlin E. Cox

July 25, 2013

Presentation

Expansion of Invasive Cardiac Services in the United States

Presenter: Jill R. Horwitz

July 24, 2013

News Daily News

欧洲经皮主动脉瓣置换术利用率与经济及报销情况相关

Yael L. Maxwell

July 12, 2013

Presentation

Geographic Variation in Cardiovascular Procedure Use Among Medicare Fee-for-Service (FFS) vs. Medicare Advantage Beneficiaries

Presenter: D Matlock

July 12, 2013

News Daily News

European TAVR Usage Tied to Economics, Reimbursement

Yael L. Maxwell

July 12, 2013

News Daily News

El Uso de la TAVR en Europa se asocia a la Economía y a los Reembolsos

Yael L. Maxwell

July 12, 2013

Presentation TVT 2013

The Case for the Hybrid OR-Cath Lab

Presenter: Michael Reardon

June 14, 2013

Presentation TVT 2013

Advantages and Design Requirements of a Hybrid Cath Lab/OR for TAVR (and Other Complex) Procedures

Presenter: Mathew Williams

June 13, 2013

Presentation TVT 2013

A Standard Cath Lab Is Sufficient for TAVR Procedures: Rouen and FRANCE 2 Experiences

Presenter: Alain Cribier

June 13, 2013

Presentation TCT Russia 2013

Early Stage Start-Ups: IP Protection, Early Funding & Beyond

Presenter: Bob Smouse

June 09, 2013

News Daily News

Meta-analysis: No Difference in Complications for Same-Day vs. Next-Day PCI Discharge

L.A. McKeown

April 26, 2013

News Daily News

Meta análisis: No se observa Diferencia alguna en las Complicaciones derivadas del Alta en PCI realizadas el Mismo Días frente a PCI realizadas al Día Siguiente

L.A. McKeown

April 26, 2013

Presentation

Same-Day Discharge After PCI: A Meta-analysis

Presenter: Kimberly M. Brayton

April 23, 2013

Presentation Fellows 2013

PCI and Interventional Trial Terminology: What You Really Need to Know

Presenter: Ajay Kirtane

April 16, 2013

Presentation Fellows 2013

My "Richest Emotional Experiences" with Complex PCI

Presenter: Jeffrey Moses

April 16, 2013

Presentation Fellows 2013

Essentials of Clinical Trial Design: Statistics 101 for the Interventionalist

Presenter: Sripal Bangalore

April 16, 2013

Presentation

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: A.R. Harrington

April 05, 2013

Advertisement

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

Duplication of Invasive Services Still Leaves Many Patients Without Timely Access

Declaración Pública de Rehospitalizaciones PCI aunque Algunos Cuestionan los Resultados

Expansion of Invasive Cardiac Services in the United States

欧洲经皮主动脉瓣置换术利用率与经济及报销情况相关

Geographic Variation in Cardiovascular Procedure Use Among Medicare Fee-for-Service (FFS) vs. Medicare Advantage Beneficiaries

European TAVR Usage Tied to Economics, Reimbursement

El Uso de la TAVR en Europa se asocia a la Economía y a los Reembolsos

The Case for the Hybrid OR-Cath Lab

Advantages and Design Requirements of a Hybrid Cath Lab/OR for TAVR (and Other Complex) Procedures

A Standard Cath Lab Is Sufficient for TAVR Procedures: Rouen and FRANCE 2 Experiences

Early Stage Start-Ups: IP Protection, Early Funding & Beyond

Meta-analysis: No Difference in Complications for Same-Day vs. Next-Day PCI Discharge

Meta análisis: No se observa Diferencia alguna en las Complicaciones derivadas del Alta en PCI realizadas el Mismo Días frente a PCI realizadas al Día Siguiente

Same-Day Discharge After PCI: A Meta-analysis

PCI and Interventional Trial Terminology: What You Really Need to Know

My "Richest Emotional Experiences" with Complex PCI

Essentials of Clinical Trial Design: Statistics 101 for the Interventionalist

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content